- Life Sciences
- Conference
mRNA-Based Therapeutics Summit
Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are glad to support RWD studies and precision oncology through RNA-seq and our multimodal data.
Multimodal Real-World Data for Accelerating Translational Research & De-Risking Drug Development: RNA Seq in Precision Oncology
Harmonized multimodal data sources can help researchers uncover actionable biomarkers and signatures of response or resistance
Whole transcriptome RNA sequencing unlocks a range of insights beyond the reach of traditional DNA-based methods, facilitating novel fusion detection, alternative splicing events, disease subtyping, and prognostic/ predictive signatures
Tempus is at the forefront of leveraging RNA sequencing data at scale to accelerate development and improve the probability of success of the next class of precision medicines
Josh SK Bell, Senior Director, Enterprise Strategy (Tempus)
Schedule a meeting with us
We'll be in touch shortly.